Error message

The page you requested does not exist. For your convenience, a search was performed using the query events tue 08 dec 1600 translation defects neurological disease.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Professor Simon Mendez-Ferrer

    The Méndez-Ferrer laboratory research focuses on the regulation of the haematopoietic stem-cell niche in health and disease. Blood stem cells reside in specialised niches which allows them to self-renew, proliferate, differentiate and migrate according...

  12. Mr Alexander Evtushenko

  13. Mr Asif Jah

    Mr Asif Jah ...

  14. Dr Callum Campbell

  15. Dr Cedric Ghevaert

    Cedric Gevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal College of Physicians, London (2000). He specialised in Haematology and became a fellow of the Royal College of...

  16. Ms Christine Anne Loreno

  17. Miss Daniella Black

  18. Dr David Fernandez-Antoran

    We use long-term human and mouse 3D primary epithelial cultures,  in vivo  cell lineage tracing, mathematical modelling, next generation sequencing methods and state-of-the-art confocal microscopy techniques to unravel the molecular responses and...

  19. Dr Dominic Gerard O'Donovan

    Corneal Pathology & Transplantation Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

  20. Miss Emma Brown

  21. Miss Emma Wong

  22. Dr Adrien Hallou

    Initially trained as a physicist and a chemist at the Ecole Normale Supérieure (Paris, France), I developed my interest for quantitative approaches of biological systems during my MPhil and PhD in Biophysics at the University of Cambridge. I am now a...

  23. Professor Andrew Flewitt

    I work in large area electronics and MEMS devices, with a particular focus on acoustic wave devices using thin film piezoelectrics. There are two applications of these. Surface acoustic wave (SAW) devices can be used to make microfluidic pumps without...

  24. Dr Andrew Bannister

    I have spent the last three decades generally messing around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone modifications together with characterization of the enzymes ...

  25. Dr Simon Cook

    In terms of basic science we are interested in how protein kinase and lipid signalling pathways control cell fate decisions such as proliferation versus differentiation and survival versus death. However, these pathways are frequently de-regulated in...

  26. Dr David Adams

    David performs forward genetic screens to uncover cancer genes and pathways and leads a programme to decode the genomes of several mouse strains. He also leads the Mouse Genomes Project and the Mouse Genetics Project. The Mouse Genomes Project is...

  27. Professor Eric Miska

    Our main goal is to understand how cells interpret genetic and epigenetic information as well as environmental cues to determine their correct cell fate, i.e. to make the decision to divide, die or differentiate. The recent discovery of a large...

  28. Professor Evis Sala

    Now based in Rome, my research in Cambridge focused on integrated diagnostics, through the clinical development and validation of functional imaging biomarkers to rapidly evaluate treatment response using physiologic and metabolic tumour habitat imaging...

  29. Dr Helen Morris

    In the Primary Care Unit I've managed and collaborated on a number of randomised controlled trials and other well-designed studies in the field of cancer and genetics in a primary care setting: 1) The GRAIDS (Genetic Risk Assessment on the Internet and...

  30. Professor Heike Laman

    F-box proteins (FBPs) are the substrate-recruiting subunits of SCF (Skp1-cullin1-FBP)-type E3 ubiquitin ligases, but ubiquitinated substrates have been identified for only a few of the sixty-nine FBPs identified in humans. The major aim of my laboratory...

  31. Dr Anna Piskorz

    I’m a molecular biologist focus on translational research in high grade serous ovarian cancer (HGSOC). I work on identification of genomic biomarkers that could be applied in clinic as diagnostic, prognostic and predictive biomarkers, helping in better...

  32. Professor Anna Philpott

    I am interested in the balance between proliferation and differentiation during development and cancer, using a range of models including embryos of the frog Xenopus laevis, mammalian cells including ES cells, and mice. I am particularly interested in...

  33. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

  34. Dr Alex Samoshkin

    I have been a Translational Technology Manager in the University of Cambridge since 2017. My primary role is to connect researchers in technology/physical sciences with clinicians and academics to develop new collaborative translational projects. I...

  35. Professor Charlotte Coles

    Charlotte Coles is Professor of Breast Cancer Clinical Oncology and NIHR Research Professor at the CRUK Cambridge Centre. Her research aims are to provide breast cancer patients with the best chance of cure with least side effects by personalising...

  36. Dr Pippa Corrie

    My research is based on improving outcomes for patients with chemoresistant cancers. I am chief investigator of the national adjuvant melanoma phase 3 trial, collaborating with Mark Middleton, Oxford, who leads associated translational studies focusing...

  37. Professor David Neal

    Group Leader in CRI with interest in androgen receptor signalling in prostate cancer. We are studying androgen regulated genes as mediators of cancer progression using a combination of techniques including genomics on human tissue (ChIP-seq and...

  38. Dr Daniel Hodson

    ... is also imposed in a highly dynamic fashion at the level of translation. Importantly, translation control is invisible to conventional gene expression profiling ...

  39. Dr Iosif Mendichovszky

    ... imaging of cancer, imaging biomarker development, the translation of novel radiolabelled pharmaceuticals to clinical practice and ...

  40. Dr Elena Provenzano

    I am lead pathologist for several research projects in breast cancer. My primary interest is the translational aspect of clinical trials particularly in the neoadjuvant setting. Current trials include ARTemis, PARTNER, PRIMETIME and Neo-RT clinical...

  41. Professor Alan Warren

    ... ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. ...

  42. Professor Folma Buss

    ... processes, cell signaling and membrane dynamics, and how defects in these molecular machines are linked to cancer, neurodegeneration and ...

  43. Dr Kate Dry

    ... and sporadic cancer, neurodegeneration, developmental defects, immune deficiencies, infertility and premature ageing ? and will ...

  44. Dr Pam Lochhead

    ... signalling pathways cause disease; including developmental defects, inflammation, diabetes, cancer and neurodegeneration. Furthermore, ...

  45. Dr Pier Paolo D'Avino

    Defects in cell division often cause abnormal distribution of the genetic material between the two daughter cells. These abnormalities generate genetic instability, which is widely considered as a major factor in the onset and development of human...

  46. Professor Sir Stephen Jackson

    ... and sporadic cancer, neurodegeneration, developmental defects, immune deficiencies, infertility and premature ageing and will suggest ...

  47. Dr Svetlana Khoronenkova

    ... leading to cell death and disease. In particular, defects in DNA repair are often linked to cancer and progressive neurological ...

  48. Professor David Rowitch

    New insight into human neurological diseases has emerged from investigation of normal pathways of ...

  49. Professor George Malliaras

    ... with the brain, with the aim of understanding and treating neurological disorders. ...

  50. Dr Madeline Lancaster

    ... namely understanding human brain development. Because neurological conditions affect features that are quintessentially human, a ...

  51. Mr Stephen Price

    ... brain to understand what structures need avoiding to prevent neurological deficits. I am also interested in the effect of radiotherapy on ...

  52. Dr Ahsan MEMON

    ... for driving cell shape changes in physiological and disease conditions. Additionally, Ahsan has designed a device capable of ...

  53. Dr Andrew Murray

    Our interest lies in the control of mitochondrial respiration and energy metabolism. We are interested in the metabolic response to dietary manipulation and alterations in oxygen supply, including the matching of oxygen demand and supply. We study this...

  54. Dr Alasdair Russell

    ... range of pre-clinical trials to advance our understanding of disease. ...

  55. Mr Amit Roshan

    ... in early melanoma, and progressing our understanding of disease mechanisms in the initiation and progression of localised melanoma. ...

  56. Professor Anthony Davenport

    ... emission tomography, to determine how these are altered with disease. Major interests are the role of endothelin-1 in human pathophysiology ...

  57. Dr Chiwen Chang

    1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.

  58. Professor Clemens Kaminski

    ... study of protein-protein interactions, which are linked to disease, in particular to cancer, Parkinson's disease and Malaria. The techniques are also used for research into molecular ...

Pages